• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / Media / About / SANE Vax Press Releases / Cervical Cancer vs Prostate Cancer: Is the FDA practicing sexual discrimination?

Cervical Cancer vs Prostate Cancer: Is the FDA practicing sexual discrimination?

March 2, 2011 By Jonathan 4 Comments

FDA advisory panels reject the use of two separate prostate cancer prevention measures yet approve cervical cancer preventive shots using virtually the same criteria. What is wrong with this picture?

FOR IMMEDIATE RELEASE

PRLog (Press Release) – Mar 01, 2011 – November 2010, an FDA advisory panel soundly rejected the proposed use of two drugs, Avodart from GlaxoSmithKline and Proscar by Merck, as a potential preventive measure for prostate cancer. It seems that although the two drugs showed promise in preventing low-grade cancer cells, they were linked to a risk of a higher incidence of high-grade cancer.For those who have been following the HPV vaccine controversy, this sounds all too familiar. The following excerpts (visit http://www.medpagetoday.com/HematologyOncology/ProstateC …for details) from a December article in MedPage, titled, “FDA Panel Rejects Prostate Drugs for CA Prevention” by Emily P. Walker:•   How to handle low-grade prostate cancer is controversial in the urology community, in part because it is unknown if the low-grade tumors would ever develop into high-grade tumors, and also because the method used to originally detect prostate cancer — the PSA test — is inexact.

•   The panel agreed that a reduction in the less-risky tumors — which may never even turn into serious cancers — is not a big enough benefit if the drugs may actually lead to life-threatening cancers. In addition, the standards need to be much higher for a chemopreventive agent.

•   “If you’re going to give normally healthy people a drug, there need to be no side effects,” said Walsh, who was brought in by the FDA as a guest speaker.

•   If approved to prevent cancer, the drugs could potentially be given to hundreds of thousands of otherwise healthy men with elevated PSAs who are concerned about dying from prostate cancer.

•   That means “we [would] use this to treat men — not patients — men who don’t have a disease,” said Richard Padzur, MD, director of oncology drugs at the FDA.

The SaneVax Team applauds the FDA advisory panel for their decision on these two drugs. We are sure it will save many men from suffering not only the potentially higher risk of prostate cancer, but also any potential adverse effects from mass administration of drugs to healthy individuals.

However, the SaneVax Team wants to know where these ‘wise’ advisors were when HPV vaccines came up for review. We want to know why the same standards were not applied to the world’s female population in regard to cervical cancer prevention that were taken into consideration when the world’s male population was reviewed for potential prostate cancer prevention. This double standard of ‘care’ is not acceptable.

•   Handling low-grade cervical cancer is just as controversial as prostate cancer. It is also not known if low-grade cervical pre-cancerous lesions will ever progress to invasive cancer. Currently approved HPV tests are inexact, just as the PSA test.

•   Less risky cervical cell changes (CIN1/2) may never turn into cervical cancer, just like less risky prostate tumors. The standards, therefore also need to be much higher for a preventive agent, such as HPV vaccines.

•   Clinical trials for both HPV vaccines also indicated a potentially higher risk of developing invasive cervical cancer when the recipients had prior exposure to HPV vaccine relevant genotypes.

•   The SaneVax Team wholeheartedly agrees with Mr. Walsh, if you are going to give normally healthy women a drug there needs to be no side effects.

•   Nevertheless, Gardasil and Cervarix were approved for use as a preventive measure for cervical cancer and are currently being administered to hundreds of thousands of previously healthy girls, with apparent total disregard for any potential adverse effects.

•   Men who didn’t have a disease would have been treated should the advisory panel have approved the two prostate medications listed above. Unlike those men, your daughters, neighbors and friends – healthy women – NOT patients – are currently being ‘treated’ despite any potential risks.

The SaneVax Team wants to know why the FDA came to opposite conclusions in the prostate cancer versus cervical cancer prevention decisions. Is it because the prostate cancer drugs were not ‘vaccines’ and thereby liability issues would exist? Or, is it simply that the advisory committees at the FDA feel men are more important than women?

Either way, it is abundantly apparent that female medical consumers must be even more cautious and well-educated than their male counterparts. It is time for the FDA, and pharmaceutical/medical industries to stop treating women like second-class citizens.

# # #

SaneVax believes only Safe, Affordable, Necessary & Effective vaccines and vaccination practices should be offered to the public. Our primary goal is to provide scientific information/resources for those concerned about vaccine safety, efficacy and need.
Read More…

Related

Filed Under: SANE Vax Press Releases Tagged With: Autoimmune Diseases, cervarix, Cervical Cancer HPV, Gardasil/Silgard, HPV, Merck, pharmaceuticals, Sane Vax, STD's, vaccinations, Vaccine Adverse Reactions

Comments

  1. Paul Kemp says

    March 3, 2011 at 12:19 am

    It is really outrageous that questionable vaccines are being tested on healthy young women and girls. Perhaps the difference in the FDA’s judgment on the two supposedly preventive treatments was influenced by the political influence of one pharmaceutical company over the other. Just a hunch, you know.

    One way or the other, I feel worse for the trusting young girls whose parents can still make their decisions for them without their consent.

    The adult men who may or may not have a serious prostate cancer developing should know better than to fall for the pharmaceutical industry’s modus operandi — Create hysteria through press releases and news reports about some scary disease, then rush some little-tested drug or vaccine out to save the target market.

    We all have a built-in immune system to prevent cancer cells from getting out of hand. We need to eat and live so we empower it, not put our trust in drugs, IMHO.

    Reply
    • Leslie Carol says

      March 3, 2011 at 5:32 pm

      Thank you Paul for your comment – and really how many ‘healthy’ girls are out there these days? Not too many, due to genetics, environment and lack of nutrition – all affecting the immune system – already bombarded by medications and vaccines. And, I am sure you will agree, we are at the tip of the iceberg on this one.

      LCB

      Reply
  2. Leslie Carol says

    March 3, 2011 at 5:33 pm

    Thank you for your post Grace.
    We heartily concur.
    The Sane Vax Team

    Reply
  3. Bill Chaffee says

    September 25, 2016 at 3:29 am

    For comparison the lung cancer death rate is 46 per 100,000 prostate cancer 20.7 per 100,000 and cervical cancer 2.3 per 100,000. But thanks to Merck the hype is on cervical cancer.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gardasil and my son’s shattered dreams

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

gadisil given to boys

5021 Emergency Room Visits Because of Gardasil, Now Given to Boys

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in